腎機能不全または継続的な腎置換療法を受けている重症患者におけるメロペネムの集団的薬理動力学
Chen Feng1, Jiangyujing Bian1, Yuchen Qu1
1Department of Pharmacy, The Second Affiliated Hospital of Soochow University, 1055 San Xiang Road, Suzhou City, 215004, Jiangsu, China.
European journal of clinical pharmacology
|August 30, 2025
まとめ
継続的な腎置換療法 (CRRT) は,腎機能不全の患者でメロペネムクリアランスを有意に増加させる. これらの集団におけるメロペネム治療の有効性には,投与量の調整が不可欠です.
科学分野:
- 薬理学について
- 腎臓科
- 感染症
背景:
- メロペネムは重症な感染症に対する重要な抗生物質です.
- 腎機能不全と継続的な腎置換療法 (CRRT) は薬剤の薬動性を有意に変化させる.
- 腎機能不全患者の治療目標を達成するために,メロペネム投与量を最適化することが不可欠です.
研究 の 目的:
- 腎機能低下患者およびCRRT患者におけるメロペネム (PK) の薬理動態を特徴づける.
- メロペネムPKの変動に影響を与える要因を特定する.
- 最適な薬物動力学/薬物動力学 (PK/PD) ターゲットに対する投与方法を評価する.
主な方法:
- NONMEMを用いた集団薬動学 (PPK) モデリング.
- メロペネム定量化のための液体染色体-タンデム質量スペクトロメトリー (LC/MS-MS).
- PK/PDのターゲットと有害事象のリスクを評価するためのモンテカルロシミュレーション
主要な成果:
- CRRTは重要な共変数であり,非CRRTの腎機能低下と比較してメロペネムクリアランスを2. 1倍増加させた.
- メロペネムPKを最もよく説明する2つのコンパートメントモデルです.
- 推薦される治療法は,CRRT患者では0. 5g q6h (3時間輸注),CRRT以外の腎機能低下患者では0. 5g q8h (1時間輸注) です.
結論:
- CRRTは腎機能障害の患者におけるメロペネム曝露に重大な影響を及ぼします.
- メロペネムを投与するCRRT患者にとって,個別化された用量戦略は極めて重要です.
さらに関連する動画
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.8K
09:02A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
4.6K
関連する概念動画
01:11Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152
01:17Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
01:30Continuous Renal Replacement Therapy
129
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
129
01:06Renal Drug Clearance: Overview
325
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
325
01:20Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
312
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
312